Cantrell Recalls Subpotent Atropine Sulfate Injection Syringes Nationwide

Plain-English summary

Cantrell Drug Company is voluntarily recalling specific lots of Atropine Sulfate Injection Solution, 0.4 mg/1 mL, in 1 mL and 2 mL syringes. The recall was initiated because the product was found to be subpotent, meaning it contained less of the active ingredient than labeled.

The affected products are identified by NDC 52533-010-45 and UPC 0100352533010453. The recall covers 450 syringes of the 1 mL size and 1,250 syringes of the 2 mL size. Specific lot numbers and expiration dates are listed in the recall details, including lots 149690, 151665, 149198, 151454, 151668, and 151962.

The product was distributed nationwide. The FDA has classified this recall as Class I, which is the most serious classification for drug recalls. Consumers and healthcare providers should stop using the affected syringes and contact their pharmacist or the recalling firm for instructions on returning the product.

The recalled product

Product

Atropine Sulfate Injection Solution, 0.4 mg/1 mL (0.4 mg/mL), in a) 1 mL syringes and b) 2 mL syringes, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-010-45, UPC: 0100352533010453

Manufacturer

Cantrell Drug Company

Category

Drug — Injection

Hazard

• subpotent-drug

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Distribution

Related recalls